Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A.M. Vitals: Could Genzyme Attract Other Suitors?
WSJ Online
Monday, July 26, 2010 - 11:04am
tags:
Genzyme, M&A, GSK, Sanofi, JNJ
Onyx's Next Blockbuster?
Forbes
Monday, July 26, 2010 - 11:02am
tags:
ONYX Pharmaceuticals, Carfilzomib, Multiple Myeloma
Sanofi-Aventis’s Biotech Play for Genzyme
NY Times, NY
Monday, July 26, 2010 - 10:58am
tags:
M&A, Sanofi, Genzyme
Jury Still Out on Exelixis's Long Term Potential
Seeking Alpha
Monday, July 26, 2010 - 10:56am
tags:
Sanofi, Novartis, GSK, Exelixis, cancer, Bristol-Myers Squibb, Arqule
GlaxoSmithKline, Anthera Pharmaceuticals: Novel Treatments for Cardiovascular Disease
Seeking Alpha
Monday, July 26, 2010 - 10:53am
tags:
GSK, Anthera, Eli Lilly, Pfizer, cardiovascular disease
Pfizer Halts Trial of Pain Drug: Biotech's Latest Mishaps
Seeking Alpha
Monday, July 26, 2010 - 10:48am
tags:
Pfizer, GSK, Novartis, Roche, Theratechnologies
FDA approves larger dose of Pfizer's Aricept
Yahoo/AP
Monday, July 26, 2010 - 10:45am
tags:
Aricept, Pfizer, FDA, Alzheimer's disease
Genzyme stock soars amid merger talk
Boston Globe, MA
Saturday, July 24, 2010 - 5:30pm
tags:
Genzyme, Sanofi
Good News for MannKind
Yahoo/Zacks
Saturday, July 24, 2010 - 3:05pm
tags:
Afrezza, MannKind, inhaled insulin, diabetes
Pfizer's Pain Drug Runs Aground
Yahoo/Zacks
Saturday, July 24, 2010 - 3:02pm
tags:
Pfizer, pain management, tanezumab, osteoarthritis
Eli Lilly Looks Great Today, but I'm Concerned About Tomorrow
Motley Fool
Saturday, July 24, 2010 - 3:01pm
tags:
Eli Lilly
Momenta Gets FDA Green Light for Generic Anti-Clotting Drug
Motley Fool
Saturday, July 24, 2010 - 3:00pm
tags:
Momenta, Novartis, Lovenox, anti-clotting
Sanofi-Aventis’s Biotech Play for Genzyme
NY Times
Saturday, July 24, 2010 - 2:58pm
tags:
Sanofi, Genzyme
AstraZeneca Likely to Double 2010 Share Buyback After Crestor Patent Win
Bloomberg
Friday, July 23, 2010 - 9:52am
tags:
patents, Crestor, AstraZeneca, stock buyback
Forest settles patent dispute over Namenda
Bloomberg Businessweek
Friday, July 23, 2010 - 9:18am
tags:
patents, Namenda, Forest Labs, Merz, Barr Laboratories, Cobalt Laboratories, Alzheimer's disease, Lupin, Teva Pharmaceuticals, Orchid Healthcare, Wockhardt, Upsher-Smith
Antidepressant Maker Euthymics Bioscience Taps $24 Million
NY Times, NY
Friday, July 23, 2010 - 9:14am
tags:
Euthymics Bioscience, antidepressants, venture capital
Cialis' success fuels Lilly push for new men's health drugs
Indianapolis Star, IN
Friday, July 23, 2010 - 8:33am
tags:
Eli Lilly, Cialis, enlarged prostate, testosterone, Acrux, Axiron
Times Are A-Changing and Tough, Says Roche
InVivo
Friday, July 23, 2010 - 7:28am
tags:
Roche, Severin Schwan, Pharma CEOs
Biotech Stock Mailbag: Exact Sciences
TheStreet.com
Friday, July 23, 2010 - 7:16am
tags:
EXACT Sciences, MannKind, Gilead Sciences, Somaxon, JNJ, Allos, Cell Therapeutics
Impax Labs Opana ER Gets Final FDA Approval
Pharmaceutical Business Review
Friday, July 23, 2010 - 7:00am
tags:
Impax Labs, Opana ER, FDA, painkillers

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.